749 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
29 Jul 04
Bristol-myers Squibb Announces Second Quarter and Six Months Sales and Earnings for 2004
12:00am
related to previously disclosed legal matters, primarily private litigation and governmental investigations related to wholesaler inventory issues … % in 2003. The lower effective tax rate was primarily driven by lower earnings in the U.S. as a result of the litigation reserves. In 2004, basic
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
29 Oct 04
Bristol-myers Squibb Announces Third Quarter and Nine Months Sales and Earnings for 2004
12:00am
driven by lower earnings in the U.S. as a result of increased reserves for litigation and restructuring and product exclusivity losses. In 2004, basic … operations in the U.S. and Europe, $36 million for litigation matters and $8 million primarily related to a milestone payment to Solvay Pharmaceuticals
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
25 Jan 06
Fourth Quarter and Twelve Months of 2005 and Announces Eps Guidance for 2006
12:00am
Advertising and promotion
Research and development
Acquired in-process R&D
-100
Provision for restructuring
-69
Litigation charges, net
-36 … on sale of equity investment
Litigation reserves
Insurance recoveries
Provision for restructuring / other
Termination of muraglitizar agreement
Gain
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
28 Jul 05
Results of Operations and Financial Condition
12:00am
% Var.
Expenses:
COGS
MS&A
Adv. & Promo.
R&D
In-process R&D
Provision for restructuring and other items
Litigation charges, net
Gain on sale …
In-process R&D
Provision for restructuring and other items
Litigation charges, net
Gain on sale of business
Equity in net income of affiliates
Other
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
24 Jul 08
Bristol-myers Squibb Continues Strong Financial Performance
12:00am
.
Statement on Cautionary Factors
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation … obligations, difficulties and delays in product development, manufacturing or sales, patent positions and the ultimate outcome of any litigation matter
8-K/A
EX-99.2
4pl0nvzhm
1 Sep 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
vun wuabvme4q
3 Feb 03
Other events
12:00am
8-K
EX-99.1
yk162
25 Jan 06
Fourth Quarter and Twelve Months of 2005 and Announces Eps Guidance for 2006
12:00am
8-K/A
EX-99.2
29vhajoh1zg0j6 994u1
30 Oct 06
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
wtibkc83a9wtq0279qk
29 Jul 04
Bristol-myers Squibb Announces Second Quarter and Six Months Sales and Earnings for 2004
12:00am
8-K
EX-99.2
d2wv jpdbc
26 Oct 06
Bristol-myers Squibb Company Reports Financial Results for the Third
12:00am
8-K
EX-99.2
nh6twr72i k5xm
27 Jan 09
Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
12:00am
8-K
EX-99.2
c6mgmu gj
15 Mar 04
Other events
12:00am